IEQ Capital’s Caris Life Sciences CAI Stock Holding History

IEQ Capital’s Portfolio CAI Stock Details CAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-17,141	Closed	-$519K	–	2043
2025 Q3	$519K	Buy	+17,141	New	+$547K	﹤0.01%	1276

Other funds holding CAI

JHWEPV

J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM

SSP

Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

IEQ Capital's CAI Position: Q4 2025 in Review

IEQ Capital sold out of Caris Life Sciences (CAI) in Q4 2025, closing a stake of 17,141 shares — an estimated $519K sold.

IEQ Capital first reported a position in CAI in Q3 2025 and held it in 1 quarter. The position peaked at $519K in Q3 2025. 186 funds tracked by Wall St. Rank hold CAI as of Q4 2025.

IEQ Capital reported no remaining Caris Life Sciences position as of Q4 2025 after selling out during the quarter.
IEQ Capital sold 17,141 Caris Life Sciences shares in Q4 2025, an estimated $519K.
IEQ Capital first reported a position in Caris Life Sciences in Q3 2025 and held it in 1 quarter.
IEQ Capital's Caris Life Sciences position peaked at $519K in Q3 2025.
186 funds tracked by Wall St. Rank held Caris Life Sciences as of Q4 2025.

Based on IEQ Capital's 13F filing for Q4 2025, filed 13 Feb 2026.